SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma	Neoplasms by Histologic Type, epithelioid hemangioendothelioma, hemangioendothelioma, hemangioma, neoplasm, vascular cancer	Recruiting	Phase 2	2026-05-26		NCT07104331

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Sarcoma Alliance for Research through Collaboration	7

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Brigham and Women's Hospital	Boston	United States	511
Dana-Farber Cancer Institute	Boston	United States	626
Sloan Kettering Institute For Cancer Research	New York	United States	2
Stanford University	Stanford	United States	213
University of Colorado	Aurora	United States	1
Washington University St. Louis	St Louis	United States	7